Mergers and acquisitions – Page 6
-
Business
Ipsen to buy Merrimack’s cancer drugs
$1bn deal covers two liposome-encapsulated formulations of approved therapies
-
Business
Takeda to buy cancer specialist Ariad
Japan’s largest drug company agrees $5.2bn deal to expand oncology portfolio and boost pipeline
-
Business
Mosaic to buy Vale Fertilizantes in $2.5bn deal
Fertiliser deal continues consolidation trend and expands Mosaic’s presence in Brazil
-
Business
Linde–Praxair merger further consolidates industrial gases
Deal will leave just three firms controlling 85% of the global market
-
Business
Mylan may lay off up to 3500 staff
The move forms part of the US generic firm’s restructuring efforts
-
Business
Lonza to buy capsule manufacturer in $5.5bn deal
Swiss pharma firm looks to strengthen its position as world’s biggest drug manufacturing subcontractor
-
Business
Pharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
Business
Pfizer pulls back on UK and Ireland facilities
€400 million manufacturing plant expansion cancelled and two facilities to close
-
Business
OCP to invest $3.7bn in Ethiopian fertiliser plant
Output from joint venture between Ethiopian government and Moroccan state phosphate group will exceed domestic demand
-
Business
EU scrutinises Syngenta–ChemChina union
European commission investigates competition concerns in agricultural megamerger
-
Business
AstraZeneca sheds multiple drugs
Spate of licensing deals for non-core products as firm further tightens R&D focus
-
Business
India’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
-
Business
Pfizer to sell Hospira Infusion Systems to ICU Medical
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
-
Business
Lilly to buy Boehringer’s pet vaccines
Deal strengthens Lilly’s animal medicine division following recent acquisition
-
Business
Lanxess to buy Chemtura for additives
€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
-
Business
Pfizer scraps plans to split
Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
-
Business
US senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
Business
Acquisition spree moves Allergan towards innovative drugs
Company acquires five companies in six weeks across three disease areas
-
Business
J&J to buy Abbott Medical Optics
Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business